Clariane SE CLARI
EURONEXT · France · Health Services
€3.41-0.34 (-9.02%)
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Clariane (ENXTPA:CLARI) has signed a new unsecured €700 million revolving credit facility with a five year maturity, replacing its previous syndicated line and adding flexibility through an accordion feature up to €900 million. Set against the new €700 million revolving facility, Clariane’s share price has shown only modest short term momentum, with a 1-week share price return of 1.02% and a year to date gain of 1.12%. However, the 1-year total shareholder return is down 5.29% and the 5-year...
Press Release21 September 2026 Signing of a new €700 million revolving credit facility maturing in 2031 Paris, 21 September 2026: following the success of its €500 million senior bonds offering completed on 8 September, Clariane (CLARI.PA – ISIN FR0010386334) announces today the signing of an unsecured and unguaranteed €700 million revolving credit facility, which replaces its existing syndicated revolving credit facility. This new revolving credit facility has a five-year maturity and includes
[09.09.2026] Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. [CLARIANE SE] Post-stabilisation Period Announcement NO STABILISATION CARRIED OUT [Further to the pre-stabilisation period announcement dated [08.09.2026] BNP Paribas (contact: Stanford Hartman telephone: 0207 595 8222) hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/596/2014))
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.